INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 28 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -98.7% | 17,734 | -98.4% | 0.00% | – |
| Q2 2020 | $313,000 | +469.1% | 1,104,589 | +297.5% | 0.00% | – |
| Q1 2020 | $55,000 | -90.7% | 277,903 | +103.4% | 0.00% | -100.0% |
| Q2 2019 | $593,000 | +143.0% | 136,601 | +216.9% | 0.00% | – |
| Q3 2018 | $244,000 | -49.9% | 43,100 | -58.6% | 0.00% | – |
| Q2 2018 | $487,000 | +407.3% | 104,112 | +584.3% | 0.00% | – |
| Q1 2018 | $96,000 | -86.0% | 15,214 | -88.6% | 0.00% | -100.0% |
| Q4 2017 | $688,000 | -4.4% | 133,500 | +66.0% | 0.00% | 0.0% |
| Q3 2017 | $720,000 | +367.5% | 80,400 | +197.8% | 0.00% | – |
| Q2 2017 | $154,000 | +133.3% | 27,000 | +108.6% | 0.00% | – |
| Q1 2017 | $66,000 | +3.1% | 12,944 | +15.6% | 0.00% | – |
| Q4 2016 | $64,000 | -58.4% | 11,200 | -57.3% | 0.00% | – |
| Q3 2016 | $154,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,125,153 | $4,951,000 | 3.63% |
| ACUTA CAPITAL PARTNERS, LLC | 2,962,568 | $13,035,000 | 2.32% |
| DAFNA Capital Management LLC | 568,600 | $2,502,000 | 1.17% |
| MEITAV INVESTMENT HOUSE LTD | 2,450,592 | $11,425,000 | 0.51% |
| SECTORAL ASSET MANAGEMENT INC | 890,386 | $3,918,000 | 0.44% |
| Avoro Capital Advisors LLC | 2,570,705 | $11,311,000 | 0.44% |
| Cormorant Asset Management, LP | 773,816 | $3,405,000 | 0.25% |
| CAXTON CORP | 64,817 | $285,000 | 0.10% |
| Migdal Insurance & Financial Holdings Ltd. | 522,067 | $2,297,000 | 0.06% |
| 683 Capital Management, LLC | 150,000 | $660,000 | 0.04% |